Breast Reconstruction with Implants and Radiation Therapy: Patient and Timing Selection Dr. Khaled Abulkhair, PhD Medical Oncology SCE, Royal College,

Slides:



Advertisements
Similar presentations
Oncologic Drugs Advisory Committee
Advertisements

Post-operative Radiotherapy for Esophageal Cancer Parag Sanghvi, M.D., M.S.P.H. Department of Radiation Medicine Esophageal Care Conference 3/26/2007.
Breast Cancer. Introduction Most common female cancer Accounts for 32% of all female cancer 211,300 new cases yearly and rising 40,000 deaths yearly.
Chemotherapy Prolongs Survival for Isolated Local or Regional Recurrence of Breast Cancer: The CALOR Trial (Chemotherapy as Adjuvant for Locally Recurrent.
Obesity at Diagnosis Is Associated with Inferior Outcomes in Hormone Receptor Positive Breast Cancer 1 The Impact of Body Mass Index (BMI) on the Efficacy.
BREAST RECONSTRUCTION FORUM
Role of Nodal Irradiation in Breast Cancer
San Antonio Breast Cancer Symposium 2007 Highlights – Radiotherapy Kathleen C. Horst, M.D. Assistant Professor Department of Radiation Oncology Stanford.
Breast Reconstruction: Outcomes Analysis Michael J Bass, MD, JD Michael J Bass Plastic Surgery, PLLC.
Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery
Clinical Relevance of HER2 Overexpression/Amplification in Patients with Small Tumor Size and Node-Negative Breast Cancer Curigliano G et al. J Clin Oncol.
Breast Cancer: Follow up and Management of recurrence Carol Marquez, M.D. Associate Professor Department of Radiation Medicine OHSU.
BIOLOGICAL PRINCIPLES OF BREAST CANCER TREAMENT Benjamin O. Anderson, M.D. Director, Breast Health Clinic Professor of Surgery and Global Health, University.
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
Radiotherapy in Carcinoma of the Breast Patrick S Swift, MD Director, Radiation Oncology Alta Bates Comprehensive Cancer Center Berkeley, CA.
“Conservative mastectomy” the nipple sparing tecnique Alberto Luini Senology Division European instiute of Oncology-Milan.
Breast Reconstruction Hemant Singhal FRCSEd FRCS(Gen) FRCSC Consultant Surgeon Senior Lecturer (Hon) Imperial College School Of Medicine These PowerPoint.
Margins: less is just as good
Hot topics in breast radiotherapy Mark Beresford.
Meta-analysis of trials of radiotherapy in DCIS Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
Controversies in the management of PSA-only recurrent disease Stephen J. Freedland, MD Associate Professor of Urology and Pathology Durham VA Medical Center.
PREOPERATIVE HYPOFRACTIONED RADIOTHERAPY IN LOCALIZED EXTREMITY/TRUNK WALL SOFT TISSUE SARCOMAS EARLY STUDY RESULTS Hanna Kosela; Milena Kolodziejczyk;
Outcome Following Limb Salvage Surgery and External Beam Radiotherapy for High Grade Soft Tissue Sarcomas of the Groin and Axilla Rapin Phimolsarnti M.D.
Postmastectomy Radiation therapy (PMRT): Who needs it in 2008? Carol Marquez, M.D. Associate Professor, Department of Radiation Medicine Oregon Health.
Hypofractionated Radiation Therapy for Early Stage Breast Cancer Patrick J. Gagnon, M.D. Resident, PGY-4 Radiation Medicine, OHSU Providence Hospital Breast.
Breast conservation in Locally advanced breast cancer Department of Endocrine Surgery College of Medicine Amrita Institute of Medical Sciences Kochi, Kerala.
William A. Barber, M.D. Piedmont Hospital
Surgery Journal Club By : Ahmad Zahmatkesh Mohammadreza Nazemian.
Ductal Carcinoma In Situ (DCIS)
Suggested guidelines for appropriate patient selection for patients undergoing Accelerated Partial Breast Irradiation at DMC. Tonya Echols Cole, MD.
 Determining the Nature of a Breast Abnormality  It is a procedure that may be used to determine whether a lump is a cyst (sac containing fluid) or a.
Sequential vs. concurrent chemoradiotherapy for locally advanced non-small cell carcinoma.
Radiation Breast Oncology Highlights of SABC 2006 Alison Bevan, MD PhD UCSF Radiation Oncology January, 2007.
Clinical Trials Evaluating the Role of Sentinel Node Resection in Patients with Early-Stage Breast Cancer Krag DN et al. Proc ASCO 2010;Abstract LBA505.
Evidence Based For invasive breast cancer BCT is Tumor excision, axillary node dissection, whole breast radiation Modified mastectomy is total mastectomy.
Targeted Intraoperative Radiotherapy versus Whole Breast Radiotherapy for Breast Cancer (TARGIT-A Trial): An International, Prospective, Randomised, Non-Inferiority.
TREATMENT Mastectomy -traditionally, treatment of breast ca has been surgical -19 century, surgical treatment : local excision ~ total mastectomy : radical.
Recent Advances in Head and Neck Cancer Robert I. Haddad, M.D., and Dong M. Shin, M.D. The NEW ENGLAND JOURNAL of MEDICINE N Engl J Med 2008;359:
The Use of Trastuzumab in the Elderly in the Adjuvant Setting and After Disease Progression in Patients with HER2-Positive Advanced Breast Cancer Dall.
HER2 POSITIVE BREAST CARCINOMA IN THE PRE AND POST ADJUVANT ANTI-HER-2 THERAPY ERA: A SINGLE ACADEMIC INSTITUTION EXPERIENCE IN THE SETTING OUTSIDE OF.
1789 patients, 1982 – 1989, premenopausal, node + or Tumor > 5cm, M0 Total mastectomy, level I + II (partly) + CMF +/- 50Gy/25fx (electrons + photons)
Radical Mastectomy is no longer the standard Improved adjuvant and neoadjuvant therapy Chemotherapy Endocrine therapy Radiation treatment Reconstruction.
Evidence for a Survival Benefit Conferred by Adjuvant Radiotherapy in a Cohort of 608 Women with Early-stage Endometrial Cancer O. Kenneth Macdonald 1,
Clinical Outcome of Reconstruction With Tissue Expanders for Patients With Breast Cancer and Mastectomy Mitsui Memorial Hospital Department of Breast and.
HERA TRIAL: 2 Years versus 1 Year of Trastuzumab After Adjuvant Chemotherapy in Women with HER2-Positive Early Breast Cancer at 8 Years of Median Follow-Up.
Basis and Outcome of Axillary Dissection for Node Negative Axilla Gurpreet Singh Dept. Of Surgery P.G.I.M.E.R. These Power Point presentations are free.
Journal Club Dr. Eyad Al-Saeed Radiation Oncology 12 January, 2008.
Milan inter-group consensus forum on adult soft tissue sarcomas Panel 1 Pathology Panel 2 Local treatment Panel 3 Systemic treatment Plenary discussion.
Literature “Radiation has a deleterious effect on autologous flap reconstruction. delayed reconstruction seems to be a safe option in most of the cases.”
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer Slideset on: Piccart-Gebhart M, Procter M, Leyland- Jones B, et al. Trastuzumab.
Department of Clinical Radiotherapy, Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK R4 한재준 1.
The impact of age on outcome in early-stage breast cancer 방사선종양학과 R2. 최진현.
방사선종양학과 - 혈액종양내과 Joint Conference 경희의료원 방사선종양학과 R4 공 문 규.
Breast Surgery in Delhi Breast Cancer Epidemiology Halsted Theory Radical Mastectomy Fisher Theory Modified Radical Mastectomy Goals of Breast Conservation.
Summary Author: Dr. C. Tom Kouroukis, MD MSc FRCPC
RCR breast radiotherapy consensus guidelines
Dr Amit Gupta Associate Professor Dept Of Surgery
Hypofractionated radiotherapy for breast cancer
Treatment With Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART) For Non-Small Cell Lung Cancer (NSCLC): The Weston Park Hospital Experience.
IMRT delivery of preoperative, high dose radiotherapy to a large volume, with Simultaneous Integrated Boost (SIB) in retroperitoneal sarcomas: The Ottawa.
Universidad de Antioquia.
Dr T P E Wells 13 July 2018 Breast SSG Bath
LESS is MORE ONCOLOGICAL SAFETY OF NIPPLE SPARING MASTECTOMY: A SYSTEMATIC REVIEW AND ANALYSIS OF PROCEDURES with a focus on a new approach Am J.
Effect of Obesity on Prognosis after Early Breast Cancer
Neoadjuvant Adjuvant Curative Palliative
Stamatia Destounis, MD, FACR, FSBI, FAIUM
Badwe RA et al. SABCS 2009;Abstract 72.
Presentation transcript:

Breast Reconstruction with Implants and Radiation Therapy: Patient and Timing Selection Dr. Khaled Abulkhair, PhD Medical Oncology SCE, Royal College, UK Ass. Professor of Clinical Oncology Mansoura University, Egypt

Reconstruction plus Radiation Therapy Myths? If implants ; better not to give RT. Higher recurrence!!! Autologous Tissues show better results after RT. Once irradiated your implant will rupture. Will muscle flap tolerate high doses of RT. Put the implant after RT! It is always the fault of the radiation oncologist!!!

To or not to reconstruct? MastectomyNipple areola full reconstruction A Woman’s right… should be discussed thoroughly with every breast cancer patient.

A Higher Recurrence? Once believed that there was a delay in detection of local recurrence in patients with immediate reconstruction. Recent evidence suggests that there is NO DELAY in detecting local recurrence in reconstructed breasts 1. Nedumpara et al. (2011) reported on a series of 691 consecutive patients undergoing mastectomy, of whom 136 (20%) underwent immediate breast reconstruction (either with latissimus dorsi flap or subpectoral implant). The median follow-up was 55 months. For the whole group or within prognostic categories, they found no differences in local recurrence, distant metastases or survival. No significant difference in survival between reconstructed and non-reconstructed breasts 1

Tell me about Radiation Therapy!

Basics Breast Surgery Mastectomy or EqualBCS/ Any residual breast tissue RT is A MUST RT +/-

Progress of (PMRT) Over time What we did prior to the 1970’s? Many patients received PMRT post surgery, RM or MRM. NSABP B-02 randomized patients after RM to receive regional radiation. No difference in overall survival but decrease in regional recurrence. Initiated in 1971, NSABP B-04 randomized patients after RM, TM, or TM + XRT if N0 and if N+ to RM or TM +XRT. Ten year results showed no difference DFS or OS among the groups. Radiation arms did show decrease in local recurrences.

What happened in the 80’s? By the mid-80’s, an excess of cardiac mortality seen in patients followed for 10 years. Meta-analysis of 7 randomized trials of PMRT initiated before 1975 showed an increase in cardiac-related deaths in those receiving RT that was almost balanced by a reduction in the deaths due to breast cancer. The excess cardiac mortality was largely due to the increase in cardiac dose from radiation to the internal mammary nodes.

Paradigm shift to Alternate hypothesis Breast cancer is both a local and systemic problem at presentation. Trials started examining less extensive surgeries. More extensive local treatment will not improve survival. Wrong Assumption

Who did we treat in the 1990’s? Due to Toxicity; indications for PMRT were limited to include only those patients with more advanced disease: T3/4, more than 4 positive nodes. The rationale for choosing these patients is the high recurrence rate 30% which radiation could reduce by half. The treatment volume typically included the chest wall, supraclavicular nodes, and axillary nodes and much less often, the internal mammary nodes. The goal of treatment was only to reduce local and regional recurrence and not to improve overall survival. Wrong Assumption

What did we learn in 1997? Two articles published in the NEJM 10/97 showed improvement in survival with PMRT in premenopausal women, all of whom also received chemotherapy (CMF). Patients enrolled in these trials were (generally) node + with the majority having only 1-3 positive nodes and the majority having tumors < 5 cm in size. Fields treated included chest wall and all regional nodes. Similar results seen in postmenopausal stage II/III women treated with Tamoxifen and PMRT, improvement in DFS and OS.

Where did we go in 2000? Many people began recommending treatment for any node positive patient following mastectomy. Intergroup study attempted to address role of PMRT in women with 1-3 positive nodes but closed in June 2003 secondary to lack of accrual. Many discussions regarding the value of treating clinically uninvolved nodes and how that may impact overall survival.

British Columbia Trial: 20 year results…. significant survival Benefit Breast Cancer Specific Survival Overall Survival

What is the downside of PMRT? Greater risk for lymphedema of breast and arm. Increased amount of lung that is fibrosed by radiation, primarily from treatment of either the supraclavicular nodes or internal mammary nodes. May expose contralateral breast to radiation. Decrease in the quality of the cosmetic outcome following reconstruction, especially with implants.

Who needs PMRT in 2008? – T3/T4 disease at presentation. – Pathologic involvement of 4 or more nodes. 3 – What about involvement of 1-3 L.N? – What about positive margins?

When positive margins are the only risk factor Hard to demonstrate the value of PMRT in patients where positive margins is the only risk factor for local recurrence. Retrospective reviews have found L.R rates of <15% without XRT. Retrospective multivariate analysis of large group in Canada found a L.R rate of >20% in those patients with positive margins who also had T2 tumor, <51 years old, grade 3, or LVSI.

Current Recommendations

Use of PMRT with Implants …Myths? Any patient irradiated with implant reconstruction will not look as good as a patient who does not receive PMRT…tissue loss, Capsular rupture and skin wrinkles? Autologous reconstruction appear to “tolerate” PMRT better, with better cosmesis. How confident we are about these statements?

Silicone Implant is a Mastectomy Procedure?

Importance of 3D Planning

RTOG …Definition of Target Area

Complications…Changing Overtime Chawla et al. (2002) reported on a series of 48 patients who were treated with RT and reconstruction. The two year complication rate was much higher in the implant reconstruction group (53%) compared to the TRAM (transverse rectus abdominis musculocutaneous) reconstruction group (12%). First impression…implants are bad and getting worse after RT… Is this true? How much bad?

Complications…Changing Overtime Cordeiro et al. (2004), 70% of 687 patients received RT, with a mean follow-up of 34 months and they were compared to 75 un- irradiated patients. 68% of the irradiated patients developed capsular contracture, compared to 40% in the un-irradiated group. Most complications were in the first 2 years!!! 80% of the irradiated group had acceptable (good to excellent) aesthetic results, compared to 88% of the un-irradiated group,

Complications…Changing Overtime Kronowitz & Robb (2009) have performed an extensive literature review of RT and breast reconstruction. For immediate reconstruction with an implant, they concluded that RT is associated with a 40% complication rate and capsular contracture and 15% extrusion rate of the implant. Also reconstructions with autologous tissue were found to have an increased rate of fibrosis and contracture if RT is delivered to the reconstruction site after the reconstruction.

Before 2011…Conclusion were There is some evidence that an immediate breast reconstruction is to be preferred to a delayed reconstruction, and that this is safe from an oncologic perspective. However, most guidelines caution the use of immediate breast reconstruction if RT is scheduled, or if there is a high chance of an indication for RT. (breast cancer treatment guidance: UK NICE guidelines 2009; Dutch national guidelines 2011). Unfortunately, the RT indication is not always certain pre-operatively.

Recent Advances: MSKCC recently published their algorithm for PMRT with implant reconstruction. They recommend placement of permanent implant after expansion during chemotherapy and before start of PMRT. If SSM i.e. no need for expansion, do it before PMRT. Dosimetry studies around metallic ports of expanders have shown no significant impact on dose or complications.

Reconstruction: before or after PMRT? A systematic review of the literature. Eur J Cancer 2014 Nov 26;50(16): Meta-analysis..Level 1 evidence 37 eligible studies complications and cosmetic outcome 4 different subgroups: -Autologous reconstruction after radiotherapy. -Definite implant reconstruction after radiotherapy. -Autologous reconstruction before radiotherapy. -Definite implant reconstruction before radiotherapy

What did they find? A large variation in complication rates (8.7–70.0%). Acceptable cosmetic outcome (41.4–93.3%) The first analysis showed more complications and a higher revision rate if an implant reconstruction was performed after radiotherapy; for autologous reconstruction fibrosis occurred more often if reconstruction was applied first. The second analysis showed no significant differences in total complication rate. Only implant failure occurred more often if applied after radiotherapy (odds ratio (OR) 3.03 [1.59–5.77]). Concluded that A definite implant reconstruction placed before radiotherapy limits the rate of complications.

Conclusion Breast reconstruction doesn’t result in a ‘perfect’ breast, but there can be many benefits; restoring her confidence, improving her image and no external prostheses to wear. You’ll also need to think about timing. Immediate reconstruction often leaves fewer scars, but delayed reconstruction will avoid un-expected complications. Remember, there is no upper time limit for having breast reconstruction. It’s always available – even years after mastectomy.

PMRT following MRM, SSM, NAC-SM with reconstruction including Implants should all follow the same principles. Immediate reconstruction is contraindicated in IBC. SSM is not yet considered safe in IBC due to the need to excise all previously involved skin making no advantages for immediate reconstruction. NAC sparing is contraindicated if Paget’s and or bloody nipple discharge. Be cautious using NAC sparing dealing with breast cancer and better to avoid if Hormone negative, Her-2+++, L-V invasion and large primaries with less than 2 cm from NAC.

If implant reconstruction is planned for those requiring mastectomy and PMRT; a staged approach is preferred starting with tissue expanders with permanent implant to be put before Radiation therapy. If SSM you can go for immediate implants. Tissue expanders of irradiated skin carries a significantly higher risk for capsular contractures, malposition and poor cosmesis. Complications happen, implant has around 30% complication rate post RT. Let the patient knows.

It is not always the fault of the radiation oncologist

1.Malata, McIntosh & Purushotham.(2000). Immediate breast reconstruction after mastectomy for cancer. British Journal of Surgery, 87, Barreau-Pouhaer, Le, et al (1992). Risk factors for failure of immediate breast reconstruction with prosthesis after mastectomy. Eur J Surg Oncol, 18, Schechter, Strom, Perkins, et al. (2005). Immediate breast reconstruction can impact postmastectomy irradiation. American Journal of Clinical Oncology, 28(5), Judith Berbers, Angela van Baardwijk, Ruud Houben, Esther Heuts, Marjolein Smidt, Kristien Keymeulen, Maud Bessems, Stefania Tuinder, Liesbeth J Boersma. 'Reconstruction: before or after postmastectomy radiotherapy?' A systematic review of the literature. Eur J Cancer 2014 Nov 26;50(16): Epub 2014 Aug 26.Judith BerbersAngela van BaardwijkRuud HoubenEsther HeutsMarjolein SmidtKristien KeymeulenMaud BessemsStefania TuinderLiesbeth J Boersma 'Reconstruction: before or after postmastectomy radiotherapy?' A systematic review of the literature.